Abbott Laboratories Q4 Profit Increases, Inline With Estimates

Abbott Laboratories

119.67 CHF 1.85%

• Charts
• News
• Analysen

Kaufen Verkaufen

(RTTNews) - Abbott Laboratories (ABT) revealed a profit for its fourth quarter that increased from last year in line with the Street estimates.

The company's bottom line totaled $9.229 billion, or $5.27 per share. This compares with $1.594 billion, or $0.91 per share, last year.

Excluding items, Abbott Laboratories reported adjusted earnings of $2.349 billion or $1.34 per share for the period.

Analysts on average had expected the company to earn $1.34 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 7.2% to $10.974 billion from $10.241 billion last year.

Abbott Laboratories earnings at a glance (GAAP) :

-Earnings: $9.229 Bln. vs. $1.594 Bln. last year. -EPS: $5.27 vs. $0.91 last year. -Revenue: $10.974 Bln vs. $10.241 Bln last year.

-Guidance: Next quarter EPS guidance: $1.05 to $1.09